The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles
Open Access
- 1 August 1998
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 28 (8) , 2384-2394
- https://doi.org/10.1002/(sici)1521-4141(199808)28:08<2384::aid-immu2384>3.0.co;2-l
Abstract
NK cells selectively lyse tumor cells which do not express one or more MHC class I alleles. The ability to discriminate between self normal or tumor cells is due to the expression of MHC class I‐specific killer inhibitory receptors (KIR). In the present study we analyzed melanoma cell lines which were highly susceptible to NK cell‐mediated lysis in spite of the expression of a complete set of HLA class I alleles. Quantitative analysis of the HLA class I expression using allele‐specific monoclonal antibodies (mAb) revealed a down‐regulation of all HLA class I molecules. Treatment of melanoma cells with IFN‐γ resulted in up‐regulation of all HLA class I alleles that was paralleled by the acquisition of resistance to lysis. That resistance to lysis reflected the up‐regulation of HLA class I molecules was revealed by the finding that mAb‐mediated masking of either KIR or their HLA class I ligands completely restored the melanoma cell lysis. These results were obtained by the use of selected NK cell clones derived either from allogeneic or autologous donors. In addition, similar results were obtained using in vitro expanded autologous NK cell populations. Our data indicate that NK cells can lyse not only melanoma cells which have lost the expression of one or more HLA class I alleles but also cells expressing a decreased amount of class I molecules.Keywords
This publication has 54 references indexed in Scilit:
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Melanoma immunotherapy: new dreams or solid hopes?Immunology Today, 1996
- CD94 and a Novel Associated Protein (94AP) Form a NK Cell Receptor Involved in the Recognition of HLA-A, HLA-B, and HLA-C AllotypesImmunity, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Molecular characterization of human CD94: A type II membrane glycoprotein related to the C‐type lectin superfamilyEuropean Journal of Immunology, 1995
- Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.The Journal of Experimental Medicine, 1995
- Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selectionEuropean Journal of Immunology, 1995
- Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.Journal of Clinical Investigation, 1991
- A preliminary analysis of the 11.th International HistocompatibilitY Workshop monoclonal antibodies *Tissue Antigens, 1990